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ABSTRACT 
Objective: The comparative effects of food restriction (FR), Diabecon treatment (DT) and their combined therapy (FR+DT) were studied in the 
regulation of alloxan-induced diabetes mellitus, alterations in thyroid hormones (TH) and oxidative stress.  
Methods: Young diabetic rats were either kept on 50% FR and/or DT (2 gm/Kg body weight) for two months and then alterations in serum glucose, 
insulin, TH concentrations, hepatic glycogen and pancreatic antioxidants along with oxidative stress markers were evaluated.  
Results: Significantly increased serum glucose, tissue stress markers with decreased TH, hepatic glycogen (P<0.0001 for all) and pancreatic 
antioxidants (P<0.05-0.001) were observed in diabetic rats. Rats kept on different therapies exhibited significant (P<0.05) improvements than 
diabetic rats in all studied parameters. FR+DT group showed a significantly more decrease in serum glucose (P<0.05) that FR or DT group, while in 
other parameters improvement was found to be more or less equally improved in all treated groups.  
Conclusion: FR appeared to mimic the effects of Diabecon in most of the indices. However, FR+DT appears to be more effective. Possibly both 
therapies ameliorate diabetes and oxidative stress following some common metabolic pathways.  
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INTRODUCTION 
Diabetes mellitus (DM) and thyroid disease have become the most 
common endocrine abnormalities in recent years [1, 2]. On one 
hand, insulin is found to affect thyroid functions in many ways, and 
on the other hand, thyroid hormones (TH) regulate carbohydrate, 
protein, lipid metabolism and pancreatic function [3]. Thus, 
abnormality in one may negatively influence the effects of the other 
[4, 5]. However, the exact mechanism of such interdependent 
complications is not well understood yet [6]. Of course, excessively 
generated free radicals were observed as an essential factor, which 
is believed to impair endocrine control and worsen metabolism [7].  
Though, food restriction (FR) can improve these alterations by 
diminishing free radical generation and enhancing the expression of 
genes involved in antioxidant defense, insulin sensitivity, β-cell functions, 
nutrient metabolism; many times patients are unable to comply with this 
for a long time [6, 7]. Therefore, alternative drug treatment is very often 
required that can mimic the effects of FR. Since, some phytochemicals 
are known to have antidiabetic, antioxidative and TH regulatory 
potential [8, 9], which also share some biochemical signaling pathways 
with FR [2, 9], we thought of using a multi-herb preparation along with 
FR. Here, Diabecon (a poly-herbal formulation) was taken as test drug. It 
is a mixture of forty-two medicinal herbs, having protective activities 
[10, 11], but its effect on diabetic complications including TH 
concentration was not studied, till date. Thus, the aims of this study were 
to investigate whether, Diabecon administration can mimic the effects of 
prolonged FR in young non-obese diabetic rats and, to determine the 
additive combined effects of FR+Diabecon treatment if any. We 
evaluated the alterations in serum glucose, insulin, hepatic glycogen and 
TH concentrations. As, hyperglycemia deteriorates the pancreatic 
antioxidant system [4, 7, 8], the possible free radical protective activities 
were also measured in the pancreas.  
MATERIALS AND METHODS 
Chemicals and drug 
All chemicals were of reagent grade. Radioimmunoassay (RIA) kits 
for estimation of total serum insulin, T3 and T4 were purchased from 
Beckman Coulter, New Delhi, India. Diabecon (Himalaya Drug 
Company, Bangalore, India, Batch no. 37200283B) was purchased 
from the registered local market store. Aqueous suspension of 
Diabecon was prepared in 0.5% Carboxymethylcellulose (CMC), a 
suspending agent and the drug was administered at a constant 
volume of 0.1 ml/rat, p. o., for two months. 
Animals 
Healthy Wistar male rats of 118±12 g (aged 4-5 w) from the 
departmental animal house were taken and used. They were 
provided standard rat feed, drinking water and kept in optimum 
environmental conditions.  
Experimental design 
Thirty-five rats were divided into five groups of seven each. Group 
1 (Control) and Group 2 (diabetic) received only 0.1 ml aqueous 
suspension of 0.5% CMC with normal diet. While group 3 (DT) 
animals were given a normal diet with Diabecon at 2 g/day, group 
4 (FR) was devoid of food by 50%, but given 0.1 ml of 0.5% CMC 
without any drug; animals of group 5 (DT+FR) were kept at 50% 
FR, but received Diabecon at 2 g/day for consecutive 60 d. On 45th 
day, 16 h fasted animals of group 2-5 were given a single injection 
of 100 mg/kg (i. p.) of alloxan monohydrate prepared in normal 
saline as was standardized earlier [4], while those of group 1 
received only 0.1 ml normal saline to ascertain the effect of the 
vehicle if any. Drug was administered at a fixed time (10:00-11:00 
AM) of the day to avoid circadian variation. At the end of the 
experiment overnight fasted animals were sacrificed by cervical 
dislocation. Blood and tissue were collected and processed as 
described earlier [4, 8].  
Biochemical analysis and statistical analysis 
Total circulating serum insulin, T3 and T4 were estimated by RIA in 
Medicare hospital, Indore, India. Serum glucose was measured using 
commercially available kits (ERBA, Transasia Biomedicals Ltd., 
Solan, India), while activities of pancreatic antioxidants (SOD, CAT, 
International Journal of Pharmacy and Pharmaceutical Sciences 
Print ISSN: 2656-0097 | Online ISSN: 0975-1491                            Vol 13, Issue 7, 2021 
Agrawal et al. 
Int J Pharm Pharm Sci, Vol 13, Issue 7, 59-62 
 
60 
GPx and GSH), oxidative stress markers (LPO, LOOH and Protein 
carbonyl) and liver glycogen content were estimated following the 
protocols as routinely used in our laboratory [4, 8, 11]. 
All values were expressed as mean±SEM. Differences in mean values 
were compared using Prism software, version 5.1 for windows, Inc., 
La Jolla, CA, USA by one-way analysis of variance (ANOVA) followed 
by t-test. P<0.05 was considered as statistically significant. 
RESULTS 
Diabetic rats showed a significantly increased level of serum glucose 
(P<0.0001) with concomitant decreased values of hepatic glycogen, 
serum insulin, T3 and T4 (P<0.0001, for all) than control rats. In the 
same group a considerably increased level of pancreatic LPO, LOOH 
and protein carbonyl (P<0.001, for all) was observed with a parallel 
decrease in the activities of SOD (P<0.01), CAT (P<0.01), GPx 
(P<0.001) and GSH (P<0.05).  
Although rats kept on DT, FR and DT+FR showed significant 
improvement in serum glucose (P<0.0001, for all), animals kept on 
combined therapy showed more decrease (P<0.05) than DT or FR rats. 
Moreover, increased values of serum insulin (P<0.001, P<0.01 and 
P<0.001 respectively); T3 (P<0.0001, P=0.138 and P<0.0001 
respectively); T4 (P<0.0001, for all) and hepatic glycogen (P<0.001, 
P<0.001 and P<0.0001 respectively) were found in DT, FR and DT+FR 
animals. In addition to this, DT rats showed considerably increased 
values of T3 (P<0.001than FR) and T4 (P<0.001than FR and DT+FR); 
while no significant difference was seen in insulin and hepatic 
glycogen. In fact, animals of DT+FR groups showed increased hepatic 
glycogen (P<0.05) as compared to that of DT animals. 
  
 
Fig. 1: Effects of different treatments on serum (a) Glucose, (b) Insulin, (c) T3 (triidothyronine) and (d) T4 (thyroxine). Cont, normal 
control group; Diab, diabetic group; DT, diabetic drug-treated group; FR, diabetic food-restricted group; DT+FR, diabetic drug+food 
restricted group. Each group has seven rats. Data expressed as mean±SEM 
 
 
Fig. 2: Effects of different treatments on (a) LPO (lipid peroxidation), (b) LOOH (lipid hydroxide), (c) protein carbonyl of pancreatic tissue 
and (d) hepatic glycogen. Cont, normal control group; Diab, diabetic group; DT, diabetic drug-treated group; FR, diabetic food-restricted 
group; DT+FR, diabetic drug+food restricted group. Each group has seven rats. Data expressed as mean±SEM 
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Fig. 3: Effects of different treatments on (a) SOD (superoxide dismutase); (b) CAT (catalase); (c) GPx (glutathione peroxidase) and (d) GSH 
(reduced glutathione) of pancreatic tissue. Cont, normal control group; Diab, diabetic group; DT, diabetic drug-treated group; FR, diabetic 
food-restricted group; DT+FR, diabetic drug+food restricted group. Each group has seven rats. Data expressed as mean±SEM 
 
In case of pancreatic SOD, a significant increased activities were 
observed in DT (P<0.01), FR (P<0.001) and DT+FR (P<0.05) groups 
than the diabetic group. Similarly, in these groups, a marked increased 
activity was seen in CAT (P<0.05, P<0.01 and P<0.01 respectively), 
GPx (P<0.01, P<0.001 and P<0.001 respectively) and GSH (P<0.05, 
P<0.01 and P<0.001 respectively). Furthermore, the values of LPO, 
LOOH and protein carbonyls were found to be decreased in DT 
(P<0.001, P<0.01 and P<0.001), FR (P<0.01, P<0.01 and P<0.001) and 
DT+FR (P<0.01, P<0.001 and P<0.001) group respectively. DT, FR and 
DT+DR animals exhibited no significant difference in studied oxidative 
stress markers, but, in case of CAT, animals given combined therapy 
showed significant increased value (P<0.01) than DT rats. 
DISCUSSION 
Present results revealed a better amelioration of alloxan-induced 
hyperglycemia by the FR+Diabecon as compared to their individual 
therapy. Although, in DT alone or in DT+FR treated groups a similar 
pattern of improvement was seen in liver glycogen, pancreatic 
antioxidants and tissue damage markers; a clear difference was 
observed in insulin and TH concentrations, suggesting that these 
two therapies possibly shared some metabolic signaling pathways 
but also served by their specific mechanism. The presently observed 
anti-hyperglycemic and protective effects of FR or Diabecon 
corroborate with the earlier reports [2, 10, 11]. However, this 
appears to be the first study revealing TH stimulatory efficacy of 
Diabecon either alone or with FR after chronic treatment.  
Alloxan is a beta-cytotoxin and is commonly used as diabetogen [5]. 
Here also its deleterious effects on the pancreas and other body 
organs were evidenced by significantly increased blood glucose and 
diminished serum insulin, TH, glycogen and cellular antioxidants, 
similar to an earlier report [8] and it imitates the common features 
of diabetes [2, 4, 8], which were found to be improved in DT, FR and 
FR+DT groups. The increased level of insulin in treated rats 
confirmed insulinotropic or β-cell protective activity of given 
therapies [12], although it was relatively less in FR rats. This is 
understandable because FR may reduce the circulatory insulin 
concentration, but it controls diabetes via increasing insulin 
sensitivity [6]. Additionally, in FR the total daily energy expenditure 
is also lessened by decreasing TH production [13].  
SOD, CAT, GPx and GSH are chief defense antioxidants that counteract 
free radicals at different stages of their production [8, 14]. In 
hyperglycemia enhanced non-specific glycation of these defense 
machineries implies their decreased activities [3, 4] which lead to 
the formation of LPO, LOOH, protein carbonyls and other stress 
molecules [3]. FR has been reported to attenuate stress-sensitive 
signaling pathways such as NF-κB, JNK/SAPK, CREB and p38 MAPK 
[5] that also upregulate the activities of an antioxidative system [7]. 
In treated animals, improved tissue LPO, LOOH and protein carbonyl 
values and enhanced antioxidative activity might be considered as a 
sound argument in the induction of protective cell signaling 
pathways [4, 15]. 
In a parallel way, some polyphenolic and flavonoid compounds of 
tested drug such as allicine, diallyl trisulfide, trigonelline, 
momorcidin, charantin, gymnemic acid and azadirachtin activate 
genes involved in metabolism, antioxidant synthesis and β-cell 
proliferation [8, 12, 15]. On the other hand, these phytochemicals 
also control diabetes by suppressing the activity of α-glucosidase 
and disaccharidases [12, 14]. As, both FR and herbal ingredients 
have been found to induce the AMPK mediated increased expression 
of SIRT1 and PGC-1α genes that directly regulate krebs cycle, β-
oxidation and protein synthesis [5, 9], which may also be 
responsible for the reduction of insulin resistance [3]. These findings 
further support the common as well as specific effects of the FR and 
drug treatment [15, 16].  
Due to excessive free radical production diabetic patients are 
relatively more prone to cardiac problems, obesity, cancer, 
atherosclerosis, alzheimer disease and thyroid disorders [6], since, 
all these diseases are linked with oxidative stress [9], present 
treatment FR or DT or their combination may be adopted as an 
efficient remedy to prevent/delay these deformities.  
CONCLUSION  
In conclusion, similar to Diabecon, FR possesses beneficial health 
effects with respect to most of the studied indices in alloxan-induced 
diabetic rats. However, FR+Diabecon treatment appears to be a 
better option. It is presumed that FR and polyherbal drug act via 
some uncommon physiological pathways, which is revealed by 
additive effects in combined therapy. Then again, decreased tissue 
peroxidation and protein carbonylation with significantly increased 
antioxidative efficacy also revealed its protective effects against 
oxidative stress. Of course, well-controlled human studies are 
needed to ascertain the benefits of these therapies.  
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